SEER stock news
This page provides real-time market news, earnings updates, and company announcements related to Seer, Inc. (SEER).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-04-17 09:17 EST
EDAP Announces Appointment of David Horn to Board of Directors
Finviz2026-02-12 12:36:09
Leading Scientists Demonstrate How Seer's Proteograph Product Suite Advances Cardiovascular and Neurodegenerative Research at US HUPO 2026
Finviz2026-02-19 12:03:42
Radoff-Jec Group recently sent an open letter to the board of directors of Seer, Inc., emphasizing the urgent need for significant strategic adjustments at the company.
老虎证券2026-02-23 13:58:34
Seer Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Full Year 2026 Outlook
Finviz2026-02-26 21:09:42
Seer Adopts Limited Duration Tax Benefit Preservation Plan to Protect its Valuable Tax Assets
Finviz2026-02-26 21:09:42
HyBryte Treatment Results to be Presented at US Cutaneous Lymphoma Consortium Annual Workshop 2026
Finviz2026-03-23 11:30:59
Castle Biosciences' DecisionDx-Melanoma Test Significantly Improves Risk Prediction Within AJCC Stages to Support Personalized, Risk-Aligned Management of Cutaneous Melanoma, Data to Be Presented at AAD 2026
Finviz2026-03-27 13:06:57
Patent Board Upholds Seer's Nano and Micro Particle Protein Enrichment Patent in a Challenge by Bruker Subsidiaries
Finviz2026-03-30 11:03:47
Positive Clinical Results from HyBryte Comparative Study Evaluating HyBryte Against Valchlor in the Treatment of Cutaneous T-Cell Lymphoma Published in Oncology and Therapy
Finviz2026-04-02 11:33:07
Seer Confirms Receipt of Unsolicited Proposal and Director Candidate Nominations from Radoff-JEC Group
Finviz2026-04-13 17:57:49
Seer Adopts Limited Duration Tax Benefit Preservation Plan to Protect its Valuable Tax Assets
Finviz2026-02-26 21:09:42
HyBryte Treatment Results to be Presented at US Cutaneous Lymphoma Consortium Annual Workshop 2026
Finviz2026-03-23 11:30:59
Castle Biosciences' DecisionDx-Melanoma Test Significantly Improves Risk Prediction Within AJCC Stages to Support Personalized, Risk-Aligned Management of Cutaneous Melanoma, Data to Be Presented at AAD 2026
Finviz2026-03-27 13:06:57
Patent Board Upholds Seer's Nano and Micro Particle Protein Enrichment Patent in a Challenge by Bruker Subsidiaries
Finviz2026-03-30 11:03:47
Positive Clinical Results from HyBryte Comparative Study Evaluating HyBryte Against Valchlor in the Treatment of Cutaneous T-Cell Lymphoma Published in Oncology and Therapy
Finviz2026-04-02 11:33:07
Seer Confirms Receipt of Unsolicited Proposal and Director Candidate Nominations from Radoff-JEC Group
Finviz2026-04-13 17:57:49
SEER stock chart
SEER stock detailsSEER stock price change
On the last trading day, SEER stock closed at 1.95 USD, with a price change of -0.77% for the day.
Trade stock perpsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more